Tag
#JPM
-
2026
-
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
-
JPMorganChase Declares Preferred Stock Dividends
-
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
-
iFAST Partners BlackRock and JPMorgan to Drive Discretionary Portfolio Adoption Among Wealth Advisers
-
JPMorganChase to Present at the UBS Financial Services Conference
-
Wonder Sciences Launches WondermedAI™ Provider Pilot During J.P. Morgan Healthcare Conference
-
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
-
Former Drawbridge Health CEO Launches Manifold Health AI at JPM to Build the First Digital Health Index Twin for Chronic Disease
-
Biokin to Present at J.P. Morgan’s 44th Annual Healthcare Conference
-
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
-
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
-
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
-
JPMorganChase Reports Fourth-Quarter and Full-Year 2025 Financial Results
-
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference
-
Sandoz CEO, Speaking at 44th Annual J.P. Morgan Healthcare Conference, Will Outline Plans to Capitalize on Unprecedented Golden Decade of Affordable Medicines Opportunity
-
Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
vVARDIS Founders Present Drill-Free Early Cavity Treatment and Unveil Global Cavity Awareness Campaign at the 2026 J.P. Morgan Healthcare Conference
-
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
-
Field Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
-
NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan’s Healthcare Event
-
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference
-
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
-
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
-
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio